Does a past abortion or miscarriage affect a woman’s risk of developing breast cancer?Does a past abortion or miscarriage affect a woman’s risk of developing breast cancer?
A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica.
Ozempic Pill Launching; Glucose Monitor Makers Warned; Thyroidectomy in Older AdultsOzempic Pill Launching; Glucose Monitor Makers Warned; Thyroidectomy in Older Adults
(MedPage Today) — The FDA approved three doses — 1.5 mg, 4 mg, and 9 mg — of a new oral semaglutide formulation for diabetes (Ozempic tablets), Novo Nordisk announced. An ad for Novo Nordisk’s weight loss pill version of semaglutide (Wegovy… (MedPage Today) — The FDA approved three doses — 1.5 mg, 4 Read More
GLP-1 drugs may protect the heart beyond weight loss, trial results suggestGLP-1 drugs may protect the heart beyond weight loss, trial results suggest
With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a class of drugs that act on receptors throughout the body, influencing insulin sensitivity, appetite regulation, inflammation and metabolic health. These therapies traditionally Read More
Denosumab discontinuation in non-metastatic breast cancer treated with AI raises vertebral fracture riskDenosumab discontinuation in non-metastatic breast cancer treated with AI raises vertebral fracture risk
Aromatase inhibitors (AIs) are a cornerstone of adjuvant therapy for hormone receptor–positive breast cancer, significantly reducing recurrence and mortality. However, by suppressing estrogen production, AIs accelerate bone loss and increase fracture risk. To counter this, antiresorptive therapies such as denosumab or bisphosphonates are widely recommended.
FDA Approves Semaglutide Pill for ObesityFDA Approves Semaglutide Pill for Obesity
This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults. This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults.
GLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer RiskGLP-1 Receptor Agonists Plus Progestins and Endometrial Cancer Risk
This cohort study compares the associations of glucagon-like peptide-1 (GLP-1) receptor agonists and of progestins with risk of endometrial cancer among US women with endometrial hyperplasia or other benign uterine pathologies. This cohort study compares the associations of glucagon-like peptide-1 (GLP-1) receptor agonists and of progestins with risk of endometrial cancer among US women with Read More
Hims pulls cheaper Wegovy pill after federal scrutinyHims pulls cheaper Wegovy pill after federal scrutiny
Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials raised concerns that the product may violate drug laws. Hims & Hers says it will stop selling a low-cost copy of a new weight-loss pill made by Novo Nordisk, after federal officials Read More
STAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patentSTAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patent
Novo Nordisk has filed a lawsuit accusing Hims & Hers of infringing on a key patent for its widely sold Wegovy weight loss treatment, a new legal tactic by the drugmaker as it tries to thwart compounded versions of its big-selling medicine. Specifically, Novo Nordisk claims the telehealth platform infringed on the patent for semaglutide, Read More
How associations between historical redlining and breast cancer survival changed over timeHow associations between historical redlining and breast cancer survival changed over time
A 1930s to 1960s residential segregation policy has been linked to shorter survival time in people with breast cancer. New research reveals that this association has changed over time, with disparities narrowing until recently. The findings are published in Cancer.
You’ve reached your weight loss goal on GLP-1 medications. What now?You’ve reached your weight loss goal on GLP-1 medications. What now?
GLP-1 drugs have ushered in a new era in weight loss. GLP-1 drugs have ushered in a new era in weight loss.